<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-BMRRDAUU</identifier><date>2022</date><creator>Gruden, Staš</creator><creator>Pečnik, Matija</creator><relation>documents/doc/B/URN_NBN_SI_doc-BMRRDAUU_001.pdf</relation><relation>documents/doc/B/URN_NBN_SI_doc-BMRRDAUU_001.txt</relation><format format_type="issue">1</format><format format_type="type">article</format><format format_type="extent">str. 63-67</format><identifier identifier_type="COBISSID_HOST">122936579</identifier><identifier identifier_type="ISSN">2820-5014</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-BMRRDAUU</identifier><language>eng</language><language>slv</language><publisher publisher_location="Ljubljana">Fakulteta za farmacijo, ŠSSFD</publisher><source>Placebo</source><rights>InC</rights><subject language_type_id="eng">antibodies</subject><subject language_type_id="eng">autoimmune disease</subject><subject language_type_id="slv">Avtoimunske bolezni</subject><subject language_type_id="slv">COVID 19</subject><subject language_type_id="eng">immune response</subject><subject language_type_id="eng">immunosuppresives</subject><subject language_type_id="slv">imunosupresivi</subject><subject language_type_id="slv">Imunski odziv</subject><subject language_type_id="slv">protitelesa</subject><subject language_type_id="slv">revmatične bolezni</subject><subject language_type_id="eng">rheumatic disease</subject><subject language_type_id="slv">SARS-CoV-2</subject><subject language_type_id="slv">učinkovitost cepljenja</subject><subject language_type_id="eng">vaccine efficacy</subject><title>Cepljenje oseb z avtoimunsko boleznijo proti covidu-19</title></Record>